Discovery Air Announces Revolving Credit Facility from Clairvest
TORONTO, March 30, 2016 /CNW/ – Discovery Air Inc. (DA.A) (“Discovery Air” or the “Corporation”) announced today that it has entered […]
Uranium One Announces Improved Financial and Operational Results for 2015 with Increased Profitability and Lower Production Cost
TORONTO, March 30, 2016 /CNW/ – Uranium One Inc. (“Uranium One”) today reported headline revenues of $324.7 million for the […]
Aquila Resources Files 2015 Financial Results and Provides Corporate Update
Shares Outstanding: 220,960,374 TORONTO, March 30, 2016 /CNW/ – Aquila Resources Inc. (TSX: AQA) (“Aquila”), a development-stage company advancing the gold- and [...]
Health -
International Bust Disrupts Criminal Gangs Smuggling Millions of Kilograms of Tobacco
OTTAWA, March 30, 2016 /CNW/ – The National Coalition Against Contraband Tobacco congratulated Sûreté du Québec provincial police, the U.S. […]
The Government of Canada to strengthen Employment Insurance
SHEDIAC, NB, March 30, 2016 /CNW/ – The Honourable Dominic Leblanc, Leader of the Government in the House of Commons and […]
Golden Queen Announces Financial Results for the Year Ending December 31, 2015
VANCOUVER, March 30, 2016 /CNW/ – Golden Queen Mining Co. Ltd. (TSX:GQM; OTCQX:GQMNF) (the “Company” or “Golden Queen”) is pleased […]
Galane Gold Ltd. Announces Rights Offering
TORONTO, March 30, 2016 /CNW/ – Galane Gold Ltd. (“Galane” or the “Company”) (TSX-V: GG) is pleased to announce that […]
Virginia Hills Oil Corp. Announces 2015 Fourth Quarter and Year End Results
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA./ TSX Venture Exchange: VHO […]
TSB launches investigation into the accident involving a Mitsubishi MU-2B in les Îles-de-la-Madeleine, Quebec
DARTMOUTH, NS, March 30, 2016 /CNW/ – Today, the Transportation Safety Board of Canada (TSB) began the Field Phase of […]
Health -
ProMetic reports its 2015 fourth quarter and year end highlights and financial results
Clinical efficacy in humans confirmed for PBI-4050 ProMetic’s plasminogen phase 2/3 clinical trial initiated ProMetic’s IVIG phase 3 clinical trial […]
